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Abstract
Interpreting technological invention as an evolutionary and recombinant search process, we study the effect of
technology brokering, i.e. creating new inventions by combining formerly disconnected but familiar technology
components, on the likelihood of inventing more useful and particularly breakthrough inventions. For evidence, we
consider 26 years of the US patent record in biotechnology. We find that recombining more familiar components and
creating new component combinations stimulate average usefulness and likelihood of breakthrough. In particular,
interaction effects illustrate how recombining more familiar components continues to foster the creation of more useful
and breakthrough inventions but only as long as the familiar components are recombined in unprecedented ways. 
Jelcodes:O31,O32
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1. Introduction 
Technological progress is a major driver of firm performance, economic growth and social 
prosperity (Schumpeter, 1934; Freeman, 1992). At the same time, technological inventions 
vary considerably in value. The value or usefulness of an invention is typically assessed by 
the extent to which it serves as prior art for subsequent technical progress (Trajtenberg, 1990; 
Harhoff et al, 1999). The large majority of technological inventions marginally improve 
existing technology and have a relatively small impact. Only a handful of inventions have a 
strong impact by serving extensively as prior art for many subsequent inventions and can be 
considered to be breakthroughs (Rosenberg, 1994). Although they are small in numbers, 
breakthroughs are generally considered as most important for value creation and growth 
(Schumpeter, 1942; Scherer and Harhoff, 2000).  
Despite their importance, we know relatively little about the evolutionary origins of 
breakthroughs and the search process governing their discovery (e.g. Rosenberg, 1994). What 
characteristics of the search process are more likely to lead to big successes? On this, the 
literature is still scarce given that most of the literature looks at explaining average usefulness 
or value of inventions (e.g. Griliches, 1998; Rosenkopf and Nerkar, 2001). An exception are 
the detailed historical analyses on the evolutionary origins of breakthroughs (e.g. Usher, 
1954; Basalla, 1988), a number of more recent qualitative case studies (e.g. Rabinow, 1996; 
Fleming, 2002; Hargadon, 2003a; Cattani, 2006), and a few empirical studies on particular 
characteristics of their origins (e.g. Dahlin and Behrens, 2005). 
The literature portrays technological invention as the result of an evolutionarily recombinant 
search process (e.g. Schumpeter, 1939; Usher, 1954; Mokyr, 1990; Scotchmer, 1991; Basalla, 
1998). This search process is typically characterized by the familiarity of the technological 
components which are being recombined and by the linkages made between these 
components, both affecting the usefulness or impact of an invention (e.g. Henderson and 
Clark, 1990; Dahlin and Behrens, 2005; Fleming, 2001).  
The more technology components are used by prior inventions, the more inventors learn 
about successful and unsuccessful applications and the better their foresight in how to reuse 
these components in different ways and contexts (e.g. Cohen and Levinthal, 1990; Hargadon, 
2003b). As such, the recombination of familiar, well-understood, components improves the 
screening and results in more useful inventions. Using patent data, Fleming (2001) confirms 
that recombining more familiar components results in more useful inventions on average. But 
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how does familiarity of components affect the likelihood of creating exceptionally valuable 
inventions? Postulating that a higher variance of success is associated with a higher mass in 
both sides of the distribution and hence a higher chance at a breakthrough, Fleming (2001) 
finds that above a certain threshold of familiarity, recombination increases the variance of 
success and hence the likelihood of breakthroughs. However, other research suggests that 
experience and learning improve average performance but reduce experimentation and 
variability (March, 1991; Levinthal and March, 1993). Reusing familiar components might 
lead to local search and learning traps. As such, firms and inventors should explore 
unfamiliar and emerging technologies in order to create breakthroughs (e.g. Ahuja and 
Lampert, 2001). In light of this research, it remains unclear why the recombination of very 
familiar technologies continues to stimulate rather than restrict the development of more 
useful and breakthrough inventions. Are there no decreasing marginal and ultimately negative 
effects associated with the recombination of familiar components, particularly for the creation 
of breakthroughs? How can such decreasing effects be avoided? Moreover, is achieving 
higher variance of inventive success necessary to ensure an increase in the probability of 
breakthrough? 
In this paper, we extend prior research by illustrating how particularly the interaction between 
the familiarity and the combination of components is key to understand the search process 
governing valuable and breakthrough inventions, as well as to understand the conditions 
under which the reuse of familiar technology can continue to drive inventive success. Relying 
on the idea that the combinatorial potential of familiar technology components is virtually 
unlimited (e.g. Romer, 1994; Weitzman, 1998), we explore technology brokering, i.e. the 
creation of new inventions by brokering formerly uncombined but familiar technologies, as 
an important search process rendering more usefulness and breakthrough inventions 
(Hargadon and Sutton, 1997; Hargadon, 2003b)i. To do so, we identify for each invention 
whether it was created by brokering formerly uncombined technologies for the first time in 
history. Subsequently, we test whether brokering formerly uncombined technology 
components results in more useful and breakthrough inventions. In addition, we study 
whether brokering allows to mitigate any potential diminishing returns from recombining 
more familiar components. To this end, we look at the interaction between component 
familiarity and new combinations. To analyze the effect of the recombinant search process on 
the usefulness of inventions, we look explicitly at the effect on the likelihood of exceptional 
success, i.e. breakthroughs, rather than on the variance of success. As an extension, we also 
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look at average usefulness to identify if the recombinant search process governing 
breakthroughs results at the same time in lower average usefulness.  
For evidence, we use 26 years of the US patent record in biotechnology, from the beginning 
of the modern biotechnology industry in 1976 until 2001 (Rothaermel, 2000). Biotechnology 
provides an interesting setting to study brokerage of formerly uncombined but familiar 
technologies. It is an interdisciplinary field of R&D bridging different fields of science and 
technology including chemistry, microbiology, biochemistry, chemical engineering and 
computer science (Smith, 2009; Phene et al., 2006). The evolution of biotechnology has been 
driven by recombining familiar but disparate strands of knowledge and technology (Phene et 
al., 2006; Smith, 2009). Moreover, biotechnology is a very innovation intensive field with 
many breakthrough discoveries over the studied period and with the large majority of 
inventions being patented (Arundel and Kabla, 1998). In line with prior empirical research, 
we use patent data to characterize both the recombinant search process and the usefulness of 
inventions. Patents provide detailed information on the components of an invention allowing 
us to trace prior use of the same components to assess their familiarity (e.g. Fleming, 2001; 
Kaplan and Vakili, 2014), and to identify inventions with formerly uncombined components 
(Fleming et al., 2007; Carnabuci and Operti, 2013). Moreover, forward citations allow us to 
identify an invention’s usefulness, i.e. its impact on subsequent technological evolution (e.g. 
Trajtenberg, 1990; Harhoff et al, 1999). Patents receiving a disproportionately large number 
of citations can be considered as breakthroughs (e.g. Ahuja and Lampert, 2001; Conti et al., 
2013). 
The results strongly support the importance of technology brokering, i.e. combining for the 
first time formerly disconnected but familiar technologies. Recombining more familiar 
components improves inventive success but only as long as the familiar components are 
recombined in unprecedented ways. Reusing familiar components in conventional 
combinations does not result in more valuable inventions. On the contrary, the threats 
inherent in the reuse of more familiar components is that they are typically used in more 
conventional combinations while the latter reduces average usefulness and the likelihood of 
breakthrough. Before we present the results in section 4, we first review the literature in 
section 2 and detail our data and empirical strategy in section 3. 
2. Literature 
2.1.  The Evolutionary Origins of Breakthroughs 
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Technological progress and innovation is an evolutionary process whose origins can be traced 
(Schumpeter, 1934; Usher, 1954; Basalla, 1988; Mokyr, 1990). For example, Usher (1954, 
p.11) defines technological invention as “the constructive assimilation of pre-existing 
elements into new synthesis”. Besides scholars from the history of technology (e.g. Usher, 
1954; Basalla, 1998), scholars from the economics and management of ideas and innovation 
acknowledged how technological novelty is driven by the recombination of pre-existing 
knowledge and technology (e.g. Nelson and Winter, 1982; Weitzman, 1998; Arthur, 2009). 
Nelson and Winter (1982) state that “the creation of any sort of novelty in art, science or 
practical life consists to a substantial extent of a recombination of conceptual and physical 
materials that were previously in existence”. Varian (2009) coins the term “combinational 
innovation” to denote the creation of innovation as a recombination of component 
technologies.  
This holds not only for inventions in general but also for breakthroughs, i.e. those 
foundational inventions with a disproportionately large impact on subsequent technological 
progress. Although breakthroughs are frequently labeled as revolutionary or discontinuous to 
prior art, they typically also have a history of technical prior art (Basalla, 1988; Levinthal, 
1998; Hargadon, 2003a; Adner and Levinthal, 2002). Also Utterback (1996) points out that 
“radical innovations often are seen to be based on the synthesis of well-known technical 
information or components”. For instance, the transistor, often labeled as a radical or 
breakthrough invention replacing vacuum tubes, has its evolutionary origins in crystal radio 
sets which preceded vacuum tubes (Basalla, 1988).  
2.2  Component familiarity, Technology Brokering and Breakthrough Invention 
Interpreting invention as a process of recombining technology components, the inventive 
search process can be characterized along two dimensions: (i) by the familiarity of the 
components which are combined and (ii) by the linkage between these components (e.g. 
Henderson and Clark, 1990; Fleming, 2001; Kaplan and Vakili, 2014).  
2.2.1. Component familiarity 
When studying the familiarity of the technology components being recombined, the literature 
has looked at how much these components have been used by prior art (Fleming, 2001; 
Kaplan and Vakili, 2014). On the one hand, the frequency of components’ prior use increases 
knowledge and understanding of successful and failed combinations, and stimulates insight in 
how to reuse the components in different combinations and contexts (e.g. Cohen and 
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Levinthal, 1990; Fleming, 2001; Hargadon, 2003b). Prior use directs inventors to successful 
combinations and to avoid less successful ones. As such, recombining well understood 
components, i.e. those used by many and recent prior inventions, will increase an invention’s 
average usefulness and the likelihood it will be a breakthrough. On the other hand, reusing 
more familiar technology might reduce experimentation and variability, making it more 
difficult to come up with something exceptionally valuable (March, 1991; Levinthal and 
March, 1993; Ahuja and Lampert, 2001). By means of patent data, Fleming (2001) studies 
the effect of component familiarity on the mean and variance of invention value, the latter 
capturing both failure and breakthrough. He finds a positive and increasing effect of reusing 
more familiar components on average value and a u-shaped effect on the variability of value. 
Initially, the reuse of familiar components decreases the variance. This would imply a lower 
probability of breakthroughs. However, above a certain level of familiarity, reuse has a 
positive and increasing effect on the variance of success. As such, recombining “very 
familiar” components is most likely to direct inventors to the discovery of more useful and 
breakthrough inventions. Fleming’s results would therefore surprisingly suggest no 
decreasing but increasing returns from familiarity on average invention value and 
breakthrough success.  
2.2.2  Technology Brokering and Breakthrough Invention 
A second dimension to characterize the recombinant search process is the nature of the 
combinations being made. Using knowledge and technology in new ways correspond to a 
search process labelled as exploration while using knowledge and technology in well-
understood ways corresponds to a search process labelled as exploitation (March, 1991). The 
literature on creativity and innovation particularly looks at new combinations of pre-existing 
knowledge or technology. Using existing components in new combinations offers the 
possibility to create completely novel inventions (e.g. Arthur, 2009). Romer (1994), 
Weitzman (1998) and Varian (2009) argue that new combinations of existing components 
provide a potentially huge source of important new discoveries. In a theoretical model, 
Weitzman (1998) illustrates how the ultimate limits to growth do not lie so much in our 
ability to generate new ideas and technology as in our ability to successfully recombine the 
existing knowledge and technology in new ways.  
The concept of technology brokering, introduced by Hargadon and Sutton (1997), refers 
explicitly to the process of creating new innovations from original combinations of familiar 
technology. These new combinations are objectively new inventions because they are built 
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from existing but previously unconnected technologies (Weitzman, 1998; Arthur, 2009; 
Varian, 2009). In fact, many of the breakthrough inventions in the past originated from 
brokering familiar but formerly uncombined components (e.g. Adner and Levinthal, 2002; 
Hargadon 2003a; 2003b). For instance, Kary Mullis’ Nobel prize winning invention of 
polymerase chain reaction (PCR), a biomedical technique for identifying and multiplying 
DNA sequences, which revolutionized technical progress in biotechnology. Kary Mullis 
described the process of inventing PCR as: “In a sense, I put together elements that were 
already there, but that’s what inventors always do. You can’t make up new elements, usually. 
The new element, if any, it was the combination, the way they were used” as cited by 
Rabinow (1996, p 6-7). Each of PCR’s components were developed before the invention of 
PCR and were available to laboratories around the globe. Du Pont even filed a law suit 
against the PCR patents arguing that all of its components existed since the 1960s and were 
invented by Gobind Khorana, another Nobel prize laureate. The novelty or inventive step 
involved in the discovery of PCR is described by Rabinow (1996, p. 7) as: “What was 
original, powerful, and significant was the concept that combined -and reconfigured- these 
existing techniques.” This perspective is in line with Levinthal (1998) and Adner and 
Levinthal (2002) who discuss how breakthroughs can originate from combining existing but 
formerly disparate technological lineages. For example, the CAT scanner resulted from 
combining X-ray technology and computer technology (Adner and Levinthal, 2002). Cattani 
(2006) describes how Corning pioneered fiber optics by redeploying familiar knowledge and 
technology in specialty glass into the new application domain of fiber optics. 
Besides anecdotal and case study evidence, the link between technology brokering and 
inventive success has not been investigated on a larger scale. Trajtenberg et al. (1997) argue 
that patents originating from the synthesis of dissimilar technology fields, as measured by 
patent classes of the cited patents, are more basic or original and diffuse more broadly. 
Rosenkopf and Nerkar (2001) find that inventions created by moving beyond local search, i.e. 
by citing more patents from other classes than the classes to which the patent itself belongs, 
are more useful or valuable. For U.S. biotechnology patents, Phene et al. (2006) find that 
patents which cite more non-biotech patents but from the same national origin are more likely 
to be breakthroughs. Similarly, Shane (2001) argues that inventions which cite patents from a 
large number of technology fields are more radical and more likely to be commercialized 
through the foundation of a new firm. Fleming (2001) studies the effect of combination 
familiarity, i.e. the number of prior patents using exactly the same combination of 
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components, on the average and variance of inventive success. He finds that combination 
familiarity improves average usefulness but reduces the variance of success and hence the 
probability of breakthrough. Finally, Dahlin and Behrens (2005) find that inventions which 
rely on a dissimilar set of prior inventions are more novel and radical. As such, all these 
studies indicate that sourcing knowledge and technology from distant technology fields result 
in more novel and valuable inventions. Bridging different fields and communities increases 
the likelihood that novel technological combinations will emerge (Hargadon, 2003a). Yet, 
none of these studies identifies inventions created by combining formerly separate 
components, neither whether such new combinations include more or less familiar 
components. As such, the impact of brokering formerly uncombined technologies on 
inventive success has not been looked at in the empirical literature. In this paper, we 
hypothesize that recombining formerly disconnected components increases an invention’s 
average usefulness and the likelihood of being a breakthrough.  
H1: Recombining formerly disconnected components will increase an invention’s 
usefulness and likelihood of being a breakthrough 
As discussed above, the familiarity of the technologies or components is an important aspect 
of the recombinant search process and affects the usefulness of inventions (e.g. Levinthal, 
1998; Fleming, 2001; Hargadon 2003a). However, it remains unclear why there are 
increasing positive rather than negative effects associated with the recombination of most 
frequently used components (Fleming, 2001). This finding stands in contrast with the 
literature on local search and learning traps which argues that firms and inventors should 
experiment with unfamiliar and emerging technologies in order to create more useful and 
breakthrough inventions (e.g. March, 1991; Ahuja and Lampert, 2001). One could expect that 
after a certain amount of reuse, the most valuable technological applications and 
combinations might have been exhausted, eventually reducing average usefulness and 
especially reducing the likelihood of becoming seminal for future technology progress. In this 
paper, we posit that such diminishing returns to the reuse of familiar components can be 
avoided by recombining the familiar components in novel ways. Recombining existing 
knowledge and technology in new ways correspond to a search process labelled as 
exploration (March, 1991). Building on the idea that the combinatorial potential of 
technology components is virtually unlimited (Romer, 1994; Weitzman, 1998), we 
hypothesize that reusing more familiar components continues to result in the creation of more 
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valuable and breakthrough inventions as long as the familiar components are recombined in 
unprecedented ways.  
H2: Recombining familiar components will increase an invention’s usefulness and 
likelihood of a breakthrough as long as the familiar components are recombined in 
unprecedented ways  
 
3. Research Setting, Data, Variables and Methodology 
3.1  Research Setting 
Biotechnology provides an interesting setting to study technology brokering given that it is an 
interdisciplinary field of R&D with a very long history. Biotechnology bridges separate fields 
of science and technology such as chemistry, microbiology, biochemistry, chemical 
engineering and computer science (Smith, 2009; Phene et al., 2006). The evolution of 
biotechnology has been driven by recombining familiar but disparate strands of knowledge 
and technology (e.g. Smith, 2009; Phene et al., 2006). For instance, Smith (2009, p. 6) 
argues: “It involves the marshalling of concepts and methodologies from a number of 
separate disciplines and applying them to a specific problem”. Moreover, it is a very 
innovation intensive field with the large majority of technological inventions being patented 
(Arundel and Kabla, 1998). Although breakthrough inventions are relatively rare, 
biotechnology experienced a significant number of breakthroughs over the years providing us 
with a sufficient number of observations to test our predictions (Smith, 2009). A milestone in 
biotechnology was the discovery of the double helix structure of DNA by Watson and Crick 
in 1953. Yet, their findings penetrated very slowly into technological inventions until Cohen 
and Boyer’s breakthrough discovery of recombinant DNA in 1973, illustrating the possibility 
to manipulate the structure of microorganisms. The beginning of the modern biotechnology 
industry is marked by the foundation of Genentech, the first biotechnology firm, in 1976 
(Rothaermel, 2000). Our study will focus on the period 1976 until 2001. 
3.2  Patent Data 
In line with prior empirical research, we use patent data to study both the recombinant search 
process behind the creation of each technological invention as well as to identify each 
invention’s impact on subsequent technological progress. While not all inventions are 
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patented, patent data includes a large share of both failed and very successful technological 
discoveries. Patent data provides a detailed window on the components or technologies used 
to create an invention. The technology classes of a patent capture the technology fields 
covered by the patent while the subclasses (currently more than 150,000) correspond to the 
different components or technologies used to create the invention (Fleming, 2001; Carnabuci 
and Operti, 2013). Unlike patent citations which might be driven by strategic considerations 
of inventors or assignees, technology subclasses are assigned by the USPTO and therefore 
provide an objective indication of the different components of an invention. In case new 
technology (sub)classes are added or existing (sub)classes altered, all patents are 
retrospectively reclassified, allowing us to consistently measure the prior use of components 
over time. To identify inventions which broker formerly uncombined components, we 
identify patents which are the first in history with particular pairwise combinations of 
subclasses (Fleming et al., 2007).  
3.3  Sample Selection 
To identify all USPTO biotechnology patents, we made use of the OECD 
classification which relies on IPC codes (OECD, 2005). Data have been extracted from the 
Patstat patent database (version October 2011) and include all patents filed at the USPTO 
between 1976 and 2001, and granted before 2004, which fall into at least one of the IPC 
classes associated with biotechnology. The sample consists of 84,119 patents. Notice that 
while the analysis is restricted to this sample of 84,119 biotechnology patents, the whole US 
patent database is used to calculate some of the variables as explained below. Information on 
patents comes from the most recent National Bureau of Economic Research (NBER) patent 
database (www.nber.org/patents) and from the Harvard patent database 
(http://dvn.iq.harvard.edu/dvn/dv/patent). 
3.4 Dependent Variables: Breakthrough, Usefulness and Failure 
We define breakthroughs as those foundational inventions that have a disproportionately 
large impact on subsequent technological progress, independent from their evolutionary 
origins or degree of novelty (e.g. Rosenberg, 1994). We follow the tradition in the literature 
by identifying breakthroughs by means of forward patent citations (e.g. Ahuja and Lampert, 
2001; Conti et al., 2013; Kaplan and Vakili, 2014). The number of citations a patent receives 
is correlated with its technological importance (Albert et al., 1991) as well as its social 
(Trajtenberg, 1990) and private value (Harhoff et al, 1999). As such, we interpret the number 
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of citations a patent receives as it usefulness or impact. In line with prior research (Sing and 
Fleming, 2010), patents receiving no forward citations are treated as failuresii. In line with 
the actual value distribution of inventions (Schumpeter, 1942, Scherer and Harhoff, 2000), 
the distribution of forward citation counts is very skewed with a large share of patents 
receiving no or very little citations and a small share of patents receiving a large number of 
citations. Therefore, it is most likely that patents receiving most citations pertain to most 
important technological inventions.  
Most prior studies have identified breakthrough patents as the top 1% or 5% in terms of 
citations received compared to patents filed in the same year and in the same primary 3-digit 
technology class (e.g. Ahuja and Lampert 2001; Singh and Fleming 2010). This definition 
assumes each technology field to have a fixed share of high impact inventions each year and 
does not compare patents across years in order to identify breakthroughs. To avoid a 
definition that forces a fixed share of breakthroughs every year while allowing similar patents 
to be compared across years, we consider the distributions of both un-truncated and truncated 
forward citations counts and identify outliers in the top of these distributions. We calculate 
for all granted US patents the count of forward citations as the number of patents citing the 
patent and the truncated count of forward citations as the number of citations received within 
5 years after application. The untruncated citation count is used to compare all patents 
sharing the same 3-digit technology class filed within the same year and the truncated citation 
count is used to compare all patents sharing the same 3-digit technology class irrespectively 
of their time of filing. For each of the distributions, we calculate the mean and standard 
deviation. Subsequently, a patent is labeled as breakthrough in case both its truncated and 
untruncated count of forward citations are larger than the mean plus three times the standard 
deviation in the respective distributions. The sample of breakthrough patents includes some 
of the most seminal inventions identified by experts as having a profound impact on 
subsequent technical progress and generating very large private and social value. For 
instance, the sample of breakthroughs includes the Cohen and Boyer recombinant DNA 
patent (US4237224) and the two polymerase chain reaction patents (US4683202 and 
US4683195) invented by Kary Mullis and colleagues. Both recombinant DNA and PCR are 
labelled by experts as some of the most important biotechnology inventions to date (e.g. 
Rabinow, 1996; Trajtenberg et al., 1997). Arts et al. (2013) provide more general validity for 
our measure of breakthrough in the field of biotechnology. The authors illustrate how patents 
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labelled as breakthrough by means of forward citations are a very strong and significant 
predictor of being externally identified as breakthrough by experts. 
3.5 Independent Variables  
New Combinations. For each patent, we calculate a measure of recombinant novelty, 
capturing the extent to which the invention is created by combining particular components or 
technologies for the first time in historyiii. To identify inventions created by brokering 
formerly disparate components, we use the 2008 US technology class concordance to go 
through all subclass assignments of all US granted patents in order to identify all previously 
uncombined pairs of subclasses (e.g. Fleming et al., 2007; Carnabuci and Operti, 2013). At 
the patent level, we construct new combinations as the patent’s number of unprecedented 
subclass pairs divided by the patent’s total number of subclass pairs. We look at the first 
combination of two technology subclasses in history independent from the order in which the 
subclasses appear on the patent document. Alternatively, prior research has used the 
cumulative number of prior patents using exactly the same combination of subclasses as a 
measure of combination familiarity (e.g., Fleming, 2001; Kaplan and Vakili, 2014). Given 
our purpose to study brokerage of formerly uncombined components, we opted for a measure 
identifying for each subclass whether it previously was combined with each of the other 
subclasses of the same invention in any kind of configuration. As such, our measure is more 
conservative. Looking at the whole set of subclasses rather than pairs of subclasses would 
imply that patents with a different number of subclasses are not compared to each other in 
order to identify recombinant novelty while they actually may be very similariv. In addition, 
this would create a bias given that patents with a large number of subclasses would almost 
per definition be classified as representing a new combination. If we identify new 
combination as patents having a set of subclasses which has never appeared before, we find 
82% of all patents have a new combination compared to 48% having a new pairwise 
combination. Finally, by averaging the number of novel subclass pairs by the patent’s total 
number of subclass pairs, we get a continuous measure ranging from zero to one, and not just 
a binary variable, which is comparable across patents with a different number of subclasses. 
Component Familiarity. To capture the extent to which an invention was created by 
recombining familiar components, i.e. components frequently used by prior inventions, we 
calculate a patent-level measure of component familiarity by taking the average familiarity of 
each of a patent’s subclasses (Fleming, 2001; Kaplan and Vakili, 2014). Individual subclass 
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familiarity is measured by the use of the same subclass by prior patents. More formally, 
familiarity of patent i’s subclass j is calculated as 
  
In line with prior research (e.g. Katila and Ahuja, 2002), we take 5 years as the time constant 
of knowledge loss, i.e. a yearly knowledge loss of 18%. See appendix 1 for an example of 
how component familiarity and new combinations are calculated for a particular patent. 
3.6 Control Variables 
We include additional invention and team level characteristics which might affect inventive 
success as control variables. Teams are found more likely to create breakthroughs compared 
to lone inventors, an effect which is partially mediated by the diversity of technical 
experience of the team and the size of their collaboration network (Singh and Fleming 2010). 
We include team size as the number of inventors on the focal patent, average experience as 
the average number of prior patents by the focal patent’s inventors, experience diversity as 
the number of technology classes at least one of the focal patent’s inventors has patented in 
before, and network size as the number of inventors at least one of the focal patent’s 
inventors has collaborated with before the filing of the focal patent. 
Finally, we include a number of invention level characteristics in line with prior research. 
First, we include patent references as the number of citations to prior patents and non-patent 
references as the number of citations to non-patent literature. In addition, we control for 
number of classes as the number of main 3-digit US technology classes. We also include the 
number of subclasses and a single subclass dummy. The latter control is necessary given 
that the recombinant search process underlying single subclass patents remains unobservable. 
For patents with a single subclass, new combinations is put to zero. Furthermore, the USPTO 
updates from time to time the classification of technology classes and subclasses, updating 
existing subclasses and creating new subclasses typically for the most successful lines of 
technology. Such a reclassification of patents creates new subclasses and subclass 
combinations after the initial patent filing. Because the ex post reclassification is likely 
related to the success of the initial inventions using the particular subclasses, we need to 
control for the potential bias. To do so, we include for each patent newest subclass as the 
minimum number of previous uses among the focal patent’s subclasses (Fleming, 2001). In 
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addition, the newest subclass variable controls for the alternative explanation that brokering 
formerly uncombined components increases inventive success because one of the 
components is relatively new, per definition increasing the likelihood of new combinations. 
As such, the positive effect of the new combinations measure could reflect the effect of 
including novel components rather than of brokering pre-existing but formerly uncombined 
components. Moreover, we include technology class dummies (3 digit) and application year 
dummies as controls. Finally, we cluster standard errors at the assignee level to control for 
remaining unobserved heterogeneity at the assignee level.  
3.7 Empirical Methodology 
To analyze the recombinant search process most commonly underlying the creation of 
breakthroughs, we estimate the likelihood of a patent being a breakthrough by means of 
probit models. In order to discover breakthroughs, inventors might need to embrace more 
uncertainty for instance by using less familiar technology or by experimenting with new 
combinations. Such an explorative search might increase the likelihood of creating 
breakthroughs but at the same time reduce the average usefulness. To this end, we also use 
negative binomial models to study the effect of technology brokering on the average 
usefulness of an invention as measured by the number of forward citations received within 
five years. Alternatively, one could estimate the effect of component familiarity and new 
combinations for different quantiles of the number of forward citations, and check to what 
extent the estimated coefficients vary across different quantiles. Results obtained from the 
quantile regressions are similar to the ones presented in the paper (results from quantile 
regressions are not reported but available upon request from the authors). To test H1 our 
independent variable of interest is new combinations where we expect a positive effect on 
breakthrough and number of forward citations.. H2 is tested by looking at the interaction of 
the two independent variables, i.e. new combinations and component familiarity. We expect a 
positive effect of the interaction on the likelihood of breakthroughs and average invention 
value (H2). To interpret the marginal effects of the different variables and their interactions, 
we use a simulation approach recommended by King et al. (2000) and Zelner (2009). To do 
so, we use the clarify package in Stata (Tomz et al., 2003). After estimating the probit model, 
the estimated coefficients are simulated thousand times based on the predicted coefficients 
and their associated confidence intervals. Subsequently, we simulate the percent change in 
the probability of a breakthrough associated with a particular change in covariates, as well as 
the confidence interval around the change in probability.  
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4. Results 
4.1 Descriptive Statistics 
Table 1 presents descriptive statistics for our sample of biotechnology patents. We find 1.5% 
of the patents to be labeled as breakthroughs using a three standard deviation cut off in 
forward citations. While representing only 1.5% of all patented inventions, breakthroughs 
receive 17% of all forward citations. They receive on average 80 citations (31 citations within 
5 years) compared to 6 citations (2 within 5 years) for the non-breakthrough patents. Using 
the more restrictive four standard deviation cut off, 0.8% of the patents are classified as 
breakthroughs while the two standard deviation cut off classifies 2.9% of the patents as 
exceptionally valuable.  
Insert table 1 
In addition, we find 48% of the patents combine at least two formerly uncombined 
technology components while the average share of new combinations is 0.19, suggesting the 
large majority of components has been combined before the invention of the focal patent. As 
illustrated in table 2, 2.2% of the patents covering new combinations are breakthroughs 
compared to 0.9% of the patents without any new combination. As such, brokering formerly 
uncombined technologies significantly increases the chance of inventing a breakthrough, 
supporting H1. Besides a larger probability of breakthrough, these inventions receive more 
citations on average. As such, brokering formerly disparate technologies seems to increase 
average and exceptional success without increasing the variance of success.  
Insert table 2 
Inventions originating from the recombination of more familiar components are less valuable 
on average and are less likely to be breakthroughs, compared to inventions reusing less 
familiar components (table 2). This might suggest that there are diminishing returns to the 
reuse of familiar technology. However, these diminishing returns only hold for the subset of 
patented inventions with a low share of new combinations. For the subset of patents with a 
below average share of new combinations, there are no significant differences in likelihood of 
breakthrough or average usefulness between patents recombining more familiar components 
and patents recombining less familiar components. By contrast, for the subset of patents with 
an above average share of new combinations, the reuse of more familiar components seems 
to have a strong positive effect on breakthrough and average usefulness, supporting H2. The 
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hazard associated with the reuse of more familiar components is that more familiar 
components are typically used in more conventional combinations. Only 7% of all 
biotechnology patents in our sample have an above average component familiarity and an 
above average share of new combinations. Nonetheless, the descriptive statistics already 
illustrate the power of creatively recombining familiar technology to stimulate inventive 
successes.  
Table A.1 in appendix displays correlations among the different variables. Some variables, 
particularly average experience, experience diversity and network size, are highly correlated. 
Multicollinearity does not seem to be an issue given that the average variance inflation 
factors (VIF) of the full models are below 3, and the VIF of each variable is below 5 (Baum, 
2006). Nonetheless, excluding the highly correlated variables does not change the results of 
the regression analysis with respect to our key explanatory variables. As expected, 
component familiarity and new combinations are negatively correlated. This negative 
correlation shows how more familiar components are typically used in more conventional 
combinations.  
4.2 Multivariate Analysis: Probability of Breakthrough 
As illustrated in Table 3, findings from the regression analysis are generally in line with our 
initial hypotheses and the results from the descriptive statistics. When looking at the 
recombinant novelty of inventions, we find strong evidence that brokering formerly disparate 
components increases the likelihood of breakthrough, supporting H1. The effect is 
substantial: a change in the share of novel combinations from 0 to 0.5 increases the 
probability of breakthrough with 95% while a change in new combinations from 0 to 1 
increases the probability of breakthrough with 263% (table 3 column 2).  
Insert table 3 
Unlike the descriptive statistics, the regression analysis shows a positive effect from 
recombining more familiar components on the probability of breakthrough (table 2 column 
2). A standard deviation increase in component familiarity is associated with a 46% increase 
in the likelihood of breakthrough. In contrast with Fleming (2001), who found a U-shaped 
relationship between component familiarity and variance of success, we do not find a 
significant non-monotonic effect of component familiarity on breakthrough (results not 
reported). Yet, we do find a critical moderator for the positive effect of component familiarity 
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on breakthrough success, namely the recombinant novelty of the focal invention. The model 
in the third column of table three includes the interaction between component familiarity and 
new combinations, and shows that component familiarity increases the probability of 
breakthrough but only insofar the components are recombined in unprecedented ways. The 
difference between recombining more or less familiar technological components remains 
insignificant as long as the recombinant novelty of the invention is low, confirming H2. 
Figure 1 illustrates the positive interaction between component familiarity and new 
combinations. For patents with a low share of new combinations, there is no difference 
between recombining either more or less familiar components on the creation of exceptional 
successes. By contrast, for patents with a high share of new combinations, using more 
familiar components increases the probability of breakthrough. The figure thus illustrates 
how breakthroughs most likely originate from brokering formerly uncombined but very 
familiar technologies. This result sheds a new insight on the moderator for the increasing 
returns from component familiarity on inventive success. Building further on more familiar 
components -standing on bigger shoulders- only allows to stand out -to see further- if these 
components are recombined in a novel fashion. 
Insert figure 1 
An alternative way of interpreting the positive interaction between component familiarity and 
new combinations is that exploiting the learning advantages from using more familiar and 
better understood components allows to improve the chances of breakthrough the higher the 
recombinant novelty of the invention. Figure 2 illustrates this interpretation of the positive 
interaction. 
Insert figure 2 
With respect to the control variables, we find a strong positive effect of experience diversity 
of the team, i.e. the number of technology fields any of the focal patent’s inventors has 
experience with. This finding is in line with the literature suggesting that valuable inventions 
most likely originate from the collaboration between inventors from different communities 
(Hargadon, 2003). Bridging different communities increases the diversity of knowledge and 
technology available for recombination and increases the likelihood that successful 
combinations will emerge. The positive effect of the number of technology classes is in line 
with this hypothesis. The fact that the coefficient of newest subclass, measuring the minimum 
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number of previous uses among the focal patent’s subclasses, is very small and insignificant 
suggest that using relatively novel components does not improve the probability of 
breakthrough. 
4.3 Multivariate Analysis: Average Usefulness  
To test whether the effect of recombining familiar technologies and formerly disparate 
technologies on breakthrough is accompanied by a higher average value, we estimate the 
same regressions but with number of citations as dependent variable (table 4). As such, we 
get a better insight into the uncertainty and risks associated with the recombinant search 
process. If technology brokering results in a lower average usefulness besides a higher 
likelihood of breakthrough, this would be evidence in support of a positive effect of 
brokering on variance of success. If technology brokering results in a higher average 
usefulness, this would be evidence in support of a mean shifting effect. 
Insert table 4 
The results in table 4 show that the effect of new combinations and component familiarity 
work in the same direction for average usefulness and breakthrough. Brokering improves 
average usefulness, even more so if accompanied by the reuse of familiar components. As for 
breakthroughs, reusing more familiar component increases average usefulness of an invention 
but only as long as the familiar components are recombined in novel ways. The biotech data 
therefore do not support the increasing variance effect but favor a mean shifting effect. 
Further evidence in support of a mean shifting effect is found by estimating the likelihood of 
breakthrough by excluding failures from the sample, i.e. by comparing breakthroughs with 
moderately valuable patents (table 3 column 9), and by estimating the average usefulness 
while excluding breakthroughs (table 4 column 4). Patents receiving no forward citations are 
treated as failures. All results indicate that brokering familiar but formerly disconnected 
technologies increases the probability from moving from failure to moderately valuable and 
from moderately valuable to breakthrough. Running regressions with failure as dependent 
variable leads to identical conclusions (results not reported but available upon request). 
4.4 Robustness Checks 
One might worry that our identification of breakthrough inventions is too strict or not strict 
enough. As an alternative for patents being three standard deviation outliers in the 
distribution of forward citations, we identify two and four standard deviation outliers 
18 
 
corresponding respectively with 3% and 0.8% of the patents being classified as breakthrough 
compared to the initial 1.5%. As shown in columns 4 and 5 of table 3, our findings remain 
consistent across these different classifications of breakthrough. The effect of new 
combinations on breakthrough becomes larger the more exceptional we define breakthroughs. 
An increase in new combinations from 0 to 1 increases the probability of success with 154% 
for two standard deviation breakthroughs, with 263% for three standard deviations 
breakthroughs (cf supra) and with 432% for four standard deviation breakthroughs. 
Recombinant novelty becomes increasingly critical for the most influential inventions. 
In addition, one might worry that our measures reflecting component familiarity and new 
combinations are biased because our sample includes patents from 1976 until 2001. Because 
our sample starts around the beginning of the modern biotechnology industry, there are 
relatively fewer patents filed before 1976 compared to later years resulting in a lower 
component familiarity and a higher likelihood of brokering formerly uncombined 
components in the early years. As a robustness check, we rerun the analysis on patents filed 
between 1990 and 2001, dropping around 21,500 patents or 26% of the sample. Our findings 
remain consistent (table 3 column 6). Further reducing the sample to patents filed between 
1995 and 2001 does not change the results (results not reported). 
Furthermore, brokering formerly uncombined components might increase inventive success 
because one of the components appears for the first time or is relatively new per definition 
resulting in new combinations. In this case, the positive effect of new combinations on 
breakthroughs could reflect the effect of including relatively new components rather than 
brokering formerly uncombined but familiar components. We can reject this alternative 
explanation because the newest subclass control is found to be an insignificant predictor of 
breakthrough and because the new combinations measure remains positive and significant 
while controlling for newest subclass. In addition, we check whether the effect of technology 
brokering holds while including a dummy variable, new subclass, being one for patents 
having a subclass which appears for the first time. As shown in table 3 column 7, new 
combinations and the interaction between new combinations and component familiarity 
remains positive and significant. The new subclass variable is negative and insignificant so 
using novel components does not affect the likelihood of a breakthrough. 
Finally, component familiarity, being the average familiarity for each of the subclasses of a 
patent, reflects both the prior and recent use of the components combined for the first time 
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and the prior use of the formerly combined components. By consequence, the positive 
interaction between new combinations and component familiarity does not necessarily reflect 
that recombining more familiar components in new ways increases the probability of 
breakthrough. Potentially, the less familiar rather than the more familiar components part of 
the same invention are recombined in new ways. To more explicitly test hypothesis H2, we 
calculate familiarity of components used in new combinations as the average familiarity of 
the components part of any new pairwise subclass combination. By doing so, we additionally 
control for the potential bias that new subclasses are retrospectively assigned to more 
valuable patents. If this would be the case, familiarity of components used in new 
combinations should have a negative and significant impact. Restricting the analysis to 
patents covering at least one new combination, we find familiarity of components used in 
new combinations to have a positive and significant effect on breakthrough supporting 
hypothesis two (table 3 column 8). Moreover, new combinations remains positive and 
significant illustrating how the share of new combinations, i.e. the degree of recombinant 
novelty, rather than just the fact of having a new combination, determines inventive success.  
5. Discussion and Conclusion 
Characterizing technological invention as an evolutionary and recombinant search process, 
this paper studies the role of technology brokering, i.e. the creation of new inventions by 
recombining formerly disconnected but familiar technology components, as a key search 
process behind the discovery of more useful and breakthrough inventions. Using USPTO 
patent data in the field of biotechnology, we identify the recombinant search process behind 
the creation of each patented invention at the time of filing, and subsequently analyze how 
successful the inventions become in the future as measured by forward citations. We 
characterize the search process by the prior and recent use of the focal invention’s 
components, i.e. component familiarity, and by the fact whether the invention was created by 
combining formerly disconnected components.  
The results strongly support the importance of brokering formerly disparate but familiar 
technologies to generate breakthrough inventions. Brokering leverages the power of reusing 
well understood technology components. Recombining frequently used rather than relatively 
novel components results in the creation of breakthroughs but only when the components are 
recombined in unprecedented ways. Besides stimulating the creation of breakthroughs, 
brokering familiar technologies trims the likelihood of failure and increases average 
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usefulness. As such, it has a mean shifting effect rather than an increasing variance effect. 
Most frequently however, familiar components are used in more conventional combinations. 
Learning and experience with technology reduces experimentation and variability, which are 
key for the discovery of breakthroughs. The reuse of familiar components in conventional 
combinations does not result in more useful inventions. On the contrary, it reduces average 
usefulness and trims the likelihood of breakthrough. 
Our findings when proven robust for other samples and specifications have important 
implications for inventors, companies, research organizations or policymakers willing to 
stimulate the creation of impactful technological discoveries. The results illustrate the power 
of combinatorial innovation, especially for breakthroughs. Teams which master the process 
of creatively recombining familiar technology will stand out (e.g. Hargadon and Sutton, 
1997). Experimenting with formerly disconnected components positively affects inventive 
success, particularly when creatively recombining familiar components. As such, the 
revolutionary nature of breakthroughs should be put into perspective. Breakthroughs, in 
biotech at least, rely to a greater extent on pre-existing knowledge and well understood 
technology used by many prior inventions (Fleming, 2001), rather than being pioneering in 
the sense of using emerging technology or lacking links to prior art (Ahuja and Lampert, 
2001). Prior and recent use of components stimulates learning about useful and useless 
applications and fosters insight in how to reuse the components in new combinations (Cohen 
and Levinthal, 1990; Hargadon, 2003a). Yet, reusing familiar components is only supportive 
in case they are recombined in a new way while new combinations positively affect inventive 
success independent from the familiarity of the components. The drawback is that reusing 
familiar components might lead to learning traps (Levinthal and March, 1993), i.e. more 
familiar components are typically used in conventional combinations. In this case, there is a 
higher probability of failure, a lower average usefulness and a lower likelihood of 
breakthroughs.  
Our paper has some limitations mostly related to the use of patent data. First, not all 
technological inventions are patented so that our sample represents only a sample of all 
inventions, probably a sample of more successful inventions. Furthermore, the discovery of 
breakthroughs is very rare. We try to mitigate these problems by limiting our study to 
biotechnology, a field in which patenting is a very common practice and characterized by 
many breakthroughs over the studied period. Extending our analysis to other fields could test 
the robustness of our findings. Second, we make the assumption that the (anticipated) value 
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of patents does not affect the indicators capturing the characteristics of the recombinant 
search process, i.e. component familiarity and new combinations. As discussed in the paper, 
this might be an issue particularly for the new combinations measure as subclasses are 
retrospectively reclassified typically for more successful lines of technology. To control for a 
potential bias, we included newest and new subclass, measured the familiarity of components 
used in new combinations, and ran the analysis for different time windows, without finding 
any evidence of a potential bias. Nevertheless, results should be interpreted with this potential 
bias in mind. Third, there might be important characteristics in the search process not 
captured by our indicators. In this paper, we limit ourselves to studying new combinations 
and component familiarity as main characteristics of the search process. Fourth, according to 
the original definition of technology brokering, it involves recombining old ideas and 
technologies in new ways by “spanning multiple, otherwise disconnected industries and 
markets and, by doing so, put themselves in a position to be the first to see how existing 
technologies in one market could be used to create breakthrough innovations in another” 
(Hargadon, 2003b). In this paper, we use unprecedented pairwise subclass combinations to 
identify inventions resulting from what we labeled in this paper as technology brokering. As 
such, our identification of brokering does not explicitly take into account whether the 
formerly uncombined technologies come from otherwise disconnected industries and 
markets, just the fact whether pre-existing and uncombined technologies are used in new 
ways. Nonetheless, the strong and significant effects of the patent’s number of classes and of 
the team’s experience diversity suggest bridging diverse communities spurs inventive 
creativity and success. Fifth, predicting rare events like breakthroughs is a difficult task and 
our models have only limited predictive power. This implies potentially important, 
potentially random, determinants of breakthroughs remain unexplained or inexplicable. The 
discovery of breakthroughs sometimes results from serendipitous observation rather than 
from an organized search process. A classic example is Alexander Fleming’s accidental 
discovery of penicillin, or Désiré Collen’s discovery of the recombinant tissue plasminogen 
activator, a protein involved in the breakdown of blood clots and used to treat strokes, and 
touted as biotechnology’s first blockbuster drug. However, serendipity does not imply the 
absence of a recurring pattern underlying the development of significant inventions. As 
Pasteur’s saying goes “luck favors the prepared mind”. By identifying some common 
characteristics in the recombinant search process underlying the discovery of breakthroughs, 
we hope our analysis at least marginally provides insight about how to turn luck on one’s 
side. 
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FIGURE 1: Probability of a Breakthrough by Component Familiarity for High versus 
Low New Combinations 
 
The dark grey plot area represents the 95% confidence interval around the estimated probability of a breakthrough for 
patents with new combinations equal to the 10th percentile, i.e. no new combinations, based on the probit model in table 3 
column 3. The light grey plot area represents the 95% confidence interval around the estimated probability of a breakthrough 
for patents with new combinations equal to the 90th percentile, i.e. 2/3 of all pairwise subclass combinations of the focal 
patent are new. 
 
FIGURE 2: Probability of a Breakthrough by New Combinations for High versus Low 
Component familiarity 
 
The dark grey plot area represents the 95% confidence interval around the estimated probability of a breakthrough for 
patents with component familiarity equal to the 10th percentile based on the probit model in table 3 column 3. The light grey 
plot area represents the 95% confidence interval around the estimated probability of a breakthrough for patents with 
component familiarity equal to the 90th percentile. 
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TABLE 1: Descriptive Statistics (n=84,119) 
Variable Description Mean Stdev. Min. Max. 
Breakthrough Binary: 3 Stdev outlier in distribution of forward citations 0.015 0.122 0.00 1.00 
Breakthrough 2 stdev Binary: 2 Stdev outlier in distribution of forward citations 0.029 0.169 0.00 1.00 
Breakthrough 4 stdev Binary: 4 Stdev outlier in distribution of forward citations 0.008 0.092 0.00 1.00 
Forward citations Number of forward citations received within 5 years 2.86 5.86 0.00 201.00 
New combinations The focal patent’s number of pairwise subclass combinations  
which appear for the first time in history divided by the focal  
patent’s total number of pairwise subclass combinations 
0.19 0.30 0.00 1.00 
Component familiarity Recent and frequent usage of the focal patent’s subclasses by 
all prior US patents (see Fleming, 2001) 
4.71 1.96 0.00 8.65 
Team size Number of inventors 1.27 0.42 0.69 3.50 
Average experience The average number of prior patents by the focal patent’s 
inventors 
1.33 1.02 0.00 6.00 
Experience diversity The number of technology classes at least one of the focal 
patent’s inventors has patented in before 
1.57 0.95 0.00 5.04 
Network size The number of inventors at least one of the focal patent’s 
inventors has collaborated with before 
1.71 1.34 0.00 6.22 
Patent references The number of backward patent citations 1.37 0.99 0.00 6.60 
Non-patent references The number of citations to non-patent literature 2.26 1.41 0.00 6.98 
Number of classes The number of technology classes 0.68 0.48 0.00 2.77 
Number of subclasses The number of technology subclasses 1.62 0.67 0.00 4.50 
Single subclass Binary: single technology subclass 0.04 0.20 0.00 1.00 
Newest subclass The minimum number of previous uses among the focal 
patent’s subclasses 
3.11 1.72 0.00 8.65 
New subclass Binary: at least one subclass appears for the first time in 
history 
0.07 0.26 0.00 1.00 
In the regression analysis, all explanatory variables are logged after adding 1 for those variables with zero values with the 
exception of binary and fractional variables  
 
Table 2: Descriptive Statistics on Component familiarity, New combinations and 
Inventive Success  
SAMPLE % of patents % breakthroughs Forward citations mean 
Full 100 1.5 2.9 
New combinations=0 52 0.9 2.5 
New combinations>0 48 2.2 3.3 
New combinations<mean 69 1.1 2.6 
New combinations>mean 31 2.5 3.5 
Component familiarity<mean 48 1.7 3.0 
Component familiarity>mean 52 1.3 2.7 
New combinations=0 and component familiarity<mean 17 1.0 2.5 
New combinations=0 and component familiarity>mean 35 0.9 2.4 
New combinations>0 and component familiarity<mean 31 2.2 3.2 
New combinations>0 and component familiarity>mean 17 2.2 3.2 
New combinations<mean and component familiarity<mean 24 1.1 2.7 
New combinations<mean and component familiarity>mean 45 1.0 2.5 
New combinations>mean and component familiarity<mean 25 2.3 3.3 
New combinations>mean and component familiarity>mean 7 3.1 4.2 
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TABLE 3: Probit Model Technology Breakthrough 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) 
VARIABLES Breakthrough Breakthrough Breakthrough Breakthrough 
2stdev 
Breakthrough 
4stdev 
Breakthrough 
 
Breakthrough 
 
Breakthrough 
 
Breakthrough 
 
SAMPLE 1976-2001 1976-2001 1976-2001 1976-2001 1976-2001 1990-2001 1976-2001 New combinations>0 Excl. failures 
          
New combinations  0.4819*** 0.6121*** 0.5413*** 0.6948*** 0.5673*** 0.6096*** 0.3768*** 0.5898*** 
  [0.079] [0.064] [0.052] [0.081] [0.078] [0.068] [0.098] [0.068] 
Component familiarity  0.0697*** 0.0288 0.0176 0.0299 0.0202 0.0280  0.0299 
  [0.018] [0.027] [0.018] [0.032] [0.031] [0.028]  [0.029] 
New combinations 
*Component familiarity 
  0.0968*** 
[0.033] 
0.1014*** 
[0.023] 
0.1012** 
[0.041] 
0.0969*** 
[0.035] 
0.0927** 
[0.041] 
 0.0880*** 
[0.034] 
Team size -0.0369 -0.0290 -0.0280 -0.0504 -0.0230 -0.0527 -0.0281 -0.0039 -0.0194 
 [0.045] [0.045] [0.045] [0.036] [0.054] [0.053] [0.045] [0.056] [0.047] 
Average experience -0.1094*** -0.1022** -0.0952** -0.0928*** -0.1218** -0.0839* -0.0952** -0.1295*** -0.0923** 
 [0.041] [0.040] [0.040] [0.030] [0.054] [0.049] [0.040] [0.039] [0.042] 
Experience diversity 0.2013*** 0.1982*** 0.1910*** 0.2072*** 0.2039*** 0.1619*** 0.1910*** 0.2156*** 0.1787*** 
 [0.038] [0.037] [0.037] [0.028] [0.046] [0.046] [0.037] [0.044] [0.039] 
Network size -0.0269 -0.0268 -0.0294 -0.0348 -0.0196 -0.0020 -0.0294 -0.0097 -0.0228 
 [0.029] [0.029] [0.029] [0.022] [0.034] [0.035] [0.029] [0.029] [0.031] 
Patent references 0.1835*** 0.1910*** 0.1842*** 0.2051*** 0.1652*** 0.1901*** 0.1841*** 0.1861*** 0.1627*** 
 [0.020] [0.020] [0.020] [0.016] [0.022] [0.023] [0.020] [0.022] [0.021] 
Non-patent references 0.0848*** 0.0817*** 0.0851*** 0.0903*** 0.0936*** 0.0776*** 0.0851*** 0.0881*** 0.0816*** 
 [0.015] [0.016] [0.016] [0.012] [0.020] [0.020] [0.016] [0.015] [0.016] 
Number of classes 0.3136*** 0.2427*** 0.2459*** 0.2714*** 0.2790*** 0.1818*** 0.2461*** 0.3534*** 0.2505*** 
 [0.043] [0.046] [0.046] [0.033] [0.057] [0.055] [0.046] [0.055] [0.047] 
Number of subclasses 0.1146*** 0.1288*** 0.1316*** 0.0959*** 0.1254*** 0.1078*** 0.1316*** 0.1854*** 0.1178*** 
 [0.033] [0.032] [0.032] [0.024] [0.039] [0.037] [0.032] [0.040] [0.034] 
Single subclass 0.2626*** 0.3725*** 0.3266*** 0.2850*** 0.4064*** 0.2711** 0.3282***  0.3120*** 
 [0.097] [0.102] [0.096] [0.072] [0.119] [0.108] [0.098]  [0.101] 
Newest subclass -0.0106 -0.0018 0.0175 0.0155 0.0386* 0.0268 0.0173 0.0486* 0.0196 
 [0.014] [0.017] [0.018] [0.013] [0.021] [0.020] [0.018] [0.026] [0.019] 
New subclass       -0.0190   
       [0.122]   
Familiarity components 
used in new combinations 
       0.0289* 
[0.017] 
 
Year fixed effects Incl. Incl. Incl. Incl. Incl. Incl. Incl. Incl. Incl. 
Technology fixed effects Incl. Incl. Incl. Incl. Incl. Incl. Incl. Incl. Incl. 
          
Log likelihood -5643.1052 -5612.6824 -5603.4974 -9606.3937 -3446.8549 -4222.2669 -5603.49 -3564.5516 -5209.7608 
Observations 84,119 84,119 84,119 84,119 84,119 62,628 84,119 40,521 53,586 
Variables used in interaction terms are centered, Robust standard errors in brackets, Clustered at assignee level, *** p<0.01, ** p<0.05, * p<0.1 
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TABLE 4: Negative Binomial Model Forward Citations  
 (1) (2) (3) (4) 
VARIABLES Forward cit. Forward cit. Forward cit. Forward cit. 
 
SAMPLE 
    
Excl. breakthroughs 
     
New combinations  0.3080*** 0.4705*** 0.3192*** 
  [0.055] [0.047] [0.038] 
Component familiarity  0.0423*** 0.0178 0.0059 
  [0.011] [0.011] [0.008] 
New combinations*Component familiarity   0.0806*** 0.0647*** 
   [0.017] [0.011] 
Team size -0.1222*** -0.1171*** -0.1171*** -0.0886*** 
 [0.029] [0.028] [0.028] [0.024] 
Average experience -0.0922*** -0.0893*** -0.0825*** -0.0732*** 
 [0.027] [0.027] [0.027] [0.020] 
Experience diversity 0.1955*** 0.1950*** 0.1890*** 0.1648*** 
 [0.022] [0.022] [0.022] [0.018] 
Network size -0.0148 -0.0148 -0.0166 -0.0183 
 [0.017] [0.017] [0.017] [0.013] 
Patent references 0.2367*** 0.2410*** 0.2356*** 0.2126*** 
 [0.012] [0.012] [0.011] [0.010] 
Non-patent references 0.0656*** 0.0627*** 0.0650*** 0.0563*** 
 [0.009] [0.009] [0.009] [0.007] 
Number of classes 0.1246*** 0.0816*** 0.0840*** 0.0533*** 
 [0.019] [0.021] [0.021] [0.017] 
Number of subclasses 0.0742*** 0.0769*** 0.0796*** 0.0637*** 
 [0.019] [0.018] [0.018] [0.014] 
Single subclass 0.1114*** 0.1728*** 0.1392*** 0.0639* 
 [0.041] [0.041] [0.041] [0.037] 
Newest subclass -0.0022 0.0000 0.0172* 0.0134* 
 [0.008] [0.009] [0.009] [0.008] 
Year fixed effects Incl. Incl. Incl. Incl. 
Technology fixed effects Incl. Incl. Incl. Incl. 
     
lnalpha 0.4715*** 0.4683*** 0.4668*** 0.3184*** 
 [0.018] [0.018] [0.018] [0.014] 
Log likelihood -173742.84 -173664.82 -173625.55 -163923.31 
Observations 84,119 84,119 84,119 82,843 
Variables used in interaction terms are centered, Robust standard errors in brackets, Clustered at assignee level,  
*** p<0.01, ** p<0.05, * p<0.1 
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Appendix 
TABLE A.1: Example calculation component familiarity and new combinations for 
US4683195 
While working for Cetus Corporation, Kary Mullis and colleagues developed polymerase chain 
reaction (PCR), a biomedical technique for identifying and multiplying DNA. This resulted in 
two patents and Kary Mullis receiving the 1993 Nobel prize in chemistry. One of the two 
patents, US4683195, titled “process for amplifying, detecting, and/or-cloning nucleic acid 
sequence” was filed in 1986 and granted in 1987. By 2006, the patent received 1,460 forward 
citations illustrating its impact on subsequent technological progress. The USPTO assigned 7 
technology subclasses to the patent. As illustrated in the table below, each of these subclasses 
was previously assigned to granted patents filed before the PCR patent, ranging from 1 prior 
patent for subclass 435/91.2 to 324 prior patents for subclass 435/6. As argued by Kary Mullis 
himself (Rabinow, 1996, p 6-7), and as illustrated in the table, each of PCR’s components were 
used by prior inventions. In a next step, this prior use is corrected for a yearly knowledge loss of 
18%, and hence for the application year of prior patents covering the same subclass, resulting in 
an average component familiarity of 76.6.  
 Subclass  # prior patents # prior patents 
corrected for 
knowledge loss 
435/6 324 189.5 
435/91.2 1 0.8 
435/91.41 147 84.5 
436/501 218 136.6 
436/508 42 15.1 
436/63 159 81.6 
436/94 54 28.3 
average 135 76.6 
 
For the new combinations measure, all pairwise subclass combinations of patent US4683195 are 
retrieved. Given that the patent covers 7 subclasses, there are 21 unique subclass pairs as 
illustrated in the table below. Of the 21 subclass pairs, 11 appear for the first time in the patent 
database resulting in the new combinations measure being 0.52. As such, about half of the 
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subclass pairs were used by prior patents and about half of the subclass pairs appear for the first 
time. 
Subclass pair  First time 
436/94 436/501 0 
436/94 435/91.41 1 
436/94 435/91.2 1 
436/94 435/6 0 
436/94 436/63 0 
436/94 436/508 1 
436/63 435/91.41 1 
436/63 436/501 0 
436/63 435/91.2 1 
436/63 435/6 0 
436/63 436/508 1 
436/508 435/91.2 1 
436/508 436/501 0 
436/508 435/91.41 1 
436/508 435/6 0 
436/501 435/91.2 1 
436/501 435/6 0 
436/501 435/91.41 0 
435/91.41 435/91.2 1 
435/91.41 435/6 0 
435/91.2 435/6 1 
 
TABLE A.2: Correlation Matrix (n=84,119) 
 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 
(1) Breakthrough 1.00             
(2) Forward citations 0.60 1.00            
(3) New combinations 0.04 0.05 1.00           
(4) Component familiarity -0.01 -0.03 -0.67 1.00          
(5) Team size 0.01 0.00 -0.13 0.16 1.00         
(6) Average experience 0.01 0.02 -0.12 0.17 0.13 1.00        
(7) Experience diversity 0.04 0.06 -0.10 0.13 0.36 0.81 1.00       
(8) Network size 0.01 0.02 -0.17 0.22 0.49 0.78 0.82 1.00      
(9) Patent references 0.08 0.16 0.05 -0.08 -0.03 0.14 0.16 0.07 1.00     
(10) Non-patent references 0.04 0.07 -0.15 0.26 0.04 0.01 -0.01 0.01 0.11 1.00    
(11) Number of classes 0.07 0.08 0.15 0.11 0.04 0.05 0.09 0.04 0.06 0.05 1.00   
(12) Number of subclasses 0.05 0.07 0.12 0.09 0.02 0.02 0.05 0.02 0.10 0.05 0.59 1.00  
(13) Single subclass -0.01 -0.02 -0.13 -0.08 -0.01 0.01 0.00 0.00 -0.03 -0.03 -0.29 -0.50 1.00 
(14) Newest subclass -0.04 -0.05 -0.64 0.81 0.12 0.17 0.11 0.20 -0.09 0.19 -0.11 -0.23 0.10 
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i
 According to the original definition of technology brokering (Hargadon, 2003b), it involves 
recombining old ideas and technologies in new ways by “spanning multiple, otherwise 
disconnected industries and markets and, by doing so, put themselves in a position to be the first 
to see how existing technologies in one market could be used to create breakthrough innovations 
in another”. In this paper, we do not explicitly take into account whether the formerly 
uncombined technologies come from otherwise disconnected industries and markets, just the fact 
whether formerly uncombined but existing technologies are combined in new ways. 
ii
 Given the increasing use of patents for strategic reasons, even patents without (many) forward 
citations can still be very useful for instance for extracting licensing fees or for patent blocking.  
iii
 In this paper, we explicitly focus on new combinations of technologies or components at the 
level of a single invention, i.e. a single invention is developed by combining formerly disparate 
components. However, at a different level of analysis, e.g. the entire patent portfolio of a single 
organization, the components might have been combined with the components of other 
inventions of the same portfolio. As such, our notion of new combinations varies with the level 
of analysis. We thank an anonymous reviewer for this comment.  
iv
 This potentially results in a bias given the large difference in the number of subclasses in our 
sample, ranging from 1 to 90. For instance, a patent with 50 subclasses would be treated as 
highly novel even if there would exist many prior patents covering 49 of the 50 subclasses. The 
level of recombinant novelty would be exactly the same for a patent with 10 subclasses where 
none of the subclasses has been used with each of the others in any kind of configuration. 
